Skip to content

GLOBAL WHOLEHEALTH PARTNERS CORPORATION: 10-Q filed 2021-02-16

What GLOBAL WHOLEHEALTH PARTNERS CORPORATION reported in its quarterly report filed 2021-02-16 (fiscal Q2 2021): 34 published measures, 77 facts as tagged in accession 0001262463-21-000035.

This filing

Form
10-Q (quarterly report)
Filed
2021-02-16
Fiscal period
fiscal Q2 2021
Accession
0001262463-21-000035 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GLOBAL WHOLEHEALTH PARTNERS CORPORATION filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-12-31246,512USD
At 2020-06-30181,708USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-12-31185,233USD
At 2020-06-30241,443USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-12-3161,279USD
At 2020-09-30156,933USD
At 2020-06-30-59,735USD
At 2019-12-31-30,078USD
At 2019-09-301,020USD
At 2019-06-3019,818USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-12-316,825USD
At 2020-06-3014,497USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-10-01 to 2020-12-31-185,654USD92
2020-07-01 to 2020-12-31-432,817USD184
2020-07-01 to 2020-09-30-247,163USD92
2019-10-01 to 2019-12-31-51,098USD92
2019-07-01 to 2019-12-31-69,896USD184
2019-07-01 to 2019-09-30-18,798USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-07-01 to 2020-12-31-424,089USD184
2019-07-01 to 2019-12-31-39,821USD184

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2020-10-01 to 2020-12-3122,075USD92
2020-07-01 to 2020-12-3137,460USD184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2020-07-01 to 2020-12-31419,922USD184
2019-07-01 to 2019-12-3120,000USD184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2020-07-01 to 2020-12-31-3,505USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-12-31-5,181,426USD
At 2020-06-30-4,748,609USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-12-313,020USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-10-01 to 2020-12-31-95,360USD92
2020-07-01 to 2020-12-31-296,567USD184
2019-10-01 to 2019-12-31-51,098USD92
2019-07-01 to 2019-12-31-69,896USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-12-31243,492USD
At 2020-06-30181,708USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2020-10-01 to 2020-12-3130,968USD92
2020-07-01 to 2020-12-3135,874USD184

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-12-31185,233USD
At 2020-06-30241,443USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2020-12-31651USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2020-10-01 to 2020-12-3199,847USD92
2020-07-01 to 2020-12-31305,896USD184
2019-10-01 to 2019-12-3151,098USD92
2019-07-01 to 2019-12-3169,896USD184

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2020-12-31209,598USD
At 2020-06-30152,147USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2020-10-01 to 2020-12-314,487USD92
2020-07-01 to 2020-12-319,329USD184

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2020-10-01 to 2020-12-3117,588USD92
2020-07-01 to 2020-12-3128,131USD184

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2020-10-01 to 2020-12-3118,846USD92
2020-07-01 to 2020-12-3144,457USD184
2019-10-01 to 2019-12-3129,698USD92
2019-07-01 to 2019-12-3133,996USD184

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2020-10-01 to 2020-12-3110,000USD92
2020-07-01 to 2020-12-3110,700USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-12-3159,966,358shares
At 2020-06-3059,966,358shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2020-12-316,825USD
At 2020-06-3014,497USD
At 2019-12-3197USD
At 2019-06-3019,918USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2020-12-314,752,739USD
At 2020-06-304,628,908USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2020-12-313,505USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2020-12-31485USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2020-12-3126,418USD
At 2020-06-3015,064USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2020-10-01 to 2020-12-31291USD92
2020-07-01 to 2020-12-31485USD184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2020-10-01 to 2020-12-31-90,294USD92
2020-07-01 to 2020-12-31-136,250USD184

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2020-07-01 to 2020-12-3127,987USD184

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2020-07-01 to 2020-12-31430,000USD184
2019-07-01 to 2019-12-3120,000USD184

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2020-07-01 to 2020-12-31651USD184

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2020-07-01 to 2020-12-3183,869USD184
2019-07-01 to 2019-12-3123,372USD184

Inspect the source

Entity
GLOBAL WHOLEHEALTH PARTNERS CORPORATION / CIK 0001598308
Captured
SEC response SHA-256
4f9d99cd872dc9722c93779ebb6b6945e30317a1ec9af0b414aed5d85fd78acc

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001598308.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))